4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0000947871-22-000567
Director bought 192,516 shares at an average $2.18 ($420,482)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2022-05-11 | Purchase | +64,700 | $1.79 | $115,813 | 14,690,178 | I |
| ORBIMED ADVISORS LLC Director | 2022-05-12 | Purchase | +97,094 | $2.35 | $228,171 | 14,787,272 | I |
| ORBIMED ADVISORS LLC Director | 2022-05-13 | Purchase | +30,722 | $2.49 | $76,498 | 14,817,994 | I |
| Open-market purchases · 192,516 sh · avg $2.18 · $420,482 | |||||||
Loading xslF345X03/ownership.xml…